Publications

• Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol.

  (Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, Zarnecki K, Findling JW.) J Endocr Soc. 2019 Jan 01;3(1):1-12.

• The prognostic significance of adrenocortical carcinomas identified incidentally.

  (Rossfeld KK, Maithel SK, Prescott J, Wang TS, Fields RC, Weber SM, Sicklick JK, Yopp AC, Duh QY, Solorzano CC, Votanopoulos KI, Hatzaras I, Poultsides GA, Shirley LA, and the U.S. Adrenocortical Carcinoma Study Group.) J Surg Oncol. 2018 Dec;118(7):1155-1162.

• Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.

  (Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, Campbell BH, Doffek KL, Evans DB, Wang TS.) Thyroid. 2018 11;28(11):1462-1467.

• Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.

  (Wang TS, Sosa JA.) Nat Rev Endocrinol. 2018 Nov;14(11):670-683.

• A postoperative parathyroid hormone-based algorithm to reduce symptomatic hypocalcemia following completion/total thyroidectomy: A retrospective analysis of 591 patients.

  (Mazotas IG, Yen TWF, Park J, Liu Y, Eastwood DC, Carr AA, Evans DB, Wang TS.) Surgery. 2018 10;164(4):746-753.

• Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.

  (Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC.) Ann Surg Oncol. 2018 Sep;25(9):2526-2534.

• Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database.

  (Marincola Smith P, Kiernan CM, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay J, Shirley LA, Fields RC, Jin L, Weber S, Salem A, Sicklick J, Gad S, Yopp A, Mansour J, Duh QY, Seiser N, Votanopoulos K, Levine EA, Poultsides G, Solórzano CC.) Ann Surg Oncol. 2018 Aug;25(8):2308-2315.

• Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.

  (Zhang J, Jiang J, Luo Y, Li X, Lu Z, Liu Y, Huang J, Hou Y, Pang Y, Sun MYF, Wang TS, Evans DB, Pacak K, Zhuang Z, Gao X.) Endocrine. 2018 08;61(2):216-223.

• A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.

  (Poorman CE, Ethun CG, Postlewait LM, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solórzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK.) Ann Surg Oncol. 2018 Feb;25(2):520-527.

• A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.

  (Wang TS, Kline G, Yen TW, Yin Z, Liu Y, Rilling W, So B, Findling JW, Evans DB, Pasieka JL.) World J Surg. 2018 02;42(2):466-472.

• Injection of bulking agents for laryngoplasty.

  (Snyder SK, Angelos P, Carty SE, Doherty GM, Howe JR, Lee JA, Libutti SK, Miller BS, Parangi S, Patel KN, Sippel RC, Sturgeon C, Wang TS, Yip L, Zeiger MA.) Surgery. 2018 01;163(1):6-8.

• The role and timing of parathyroid hormone determination after total thyroidectomy.

  (Mazotas IG, Wang TS.) Gland Surg. 2017 Dec;6(Suppl 1):S38-S48.